Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Update in lung cancer and mesothelioma 2012.

Literature DB >> 23855692

Update in lung cancer and mesothelioma 2012.

Charles A Powell¹, Balazs Halmos, Serge P Nana-Sinkam.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2013 PMID： 23855692 PMCID： PMC3778761 DOI： 10.1164/rccm.201304-0716UP

Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN： 1073-449X Impact factor: 21.405

× No keyword cloud information.

127 in total

1. Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy for small-sized stage IA lung cancer.

Authors: Chenxi Zhong; Wentao Fang; Teng Mao; Feng Yao; Wenhu Chen; Dingzhong Hu
Journal: Ann Thorac Surg Date: 2012-06-21 Impact factor: 4.330

2. Arsenic and lung cancer in never-smokers: lessons from Chile.

Authors: Victor D Martinez; Emily A Vucic; Stephen Lam; Wan L Lam
Journal: Am J Respir Crit Care Med Date: 2012-05-15 Impact factor: 21.405

3. Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors: Frank C Detterbeck; Sandra Zelman Lewis; Rebecca Diekemper; Doreen Addrizzo-Harris; W Michael Alberts
Journal: Chest Date: 2013-05 Impact factor: 9.410

4. ROS1 rearrangements define a unique molecular class of lung cancers.

Authors: Kristin Bergethon; Alice T Shaw; Sai-Hong Ignatius Ou; Ryohei Katayama; Christine M Lovly; Nerina T McDonald; Pierre P Massion; Christina Siwak-Tapp; Adriana Gonzalez; Rong Fang; Eugene J Mark; Julie M Batten; Haiquan Chen; Keith D Wilner; Eunice L Kwak; Jeffrey W Clark; David P Carbone; Hongbin Ji; Jeffrey A Engelman; Mari Mino-Kenudson; William Pao; A John Iafrate
Journal: J Clin Oncol Date: 2012-01-03 Impact factor: 44.544

5. Relationship and prognostic value of modified coronary artery calcium score, FEV1, and emphysema in lung cancer screening population: the MILD trial.

Authors: Nicola Sverzellati; Filippo Cademartiri; Francesca Bravi; Chiara Martini; Federica A Gira; Erica Maffei; Alfonso Marchianò; Carlo La Vecchia; Massimo De Filippo; Jan-Martin Kuhnigk; Cristina Rossi; Ugo Pastorino
Journal: Radiology Date: 2011-11-23 Impact factor: 11.105

6. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.

Authors: Youngjoo Lee; Kyong-Ah Yoon; Jungnam Joo; Donghoon Lee; Kieun Bae; Ji-Youn Han; Jin Soo Lee
Journal: Carcinogenesis Date: 2012-11-08 Impact factor: 4.944

7. Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

Authors: Thomas J Lynch; Igor Bondarenko; Alexander Luft; Piotr Serwatowski; Fabrice Barlesi; Raju Chacko; Martin Sebastian; Joel Neal; Haolan Lu; Jean-Marie Cuillerot; Martin Reck
Journal: J Clin Oncol Date: 2012-04-30 Impact factor: 44.544

8. Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression.

Authors: Melody L Stallings-Mann; Jens Waldmann; Ying Zhang; Erin Miller; Mona L Gauthier; Daniel W Visscher; Gregory P Downey; Evette S Radisky; Alan P Fields; Derek C Radisky
Journal: Sci Transl Med Date: 2012-07-11 Impact factor: 17.956

9. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.

Authors: Andrea L Kasinski; Frank J Slack
Journal: Cancer Res Date: 2012-09-10 Impact factor: 12.701

Review 10. Microenvironmental regulation of epithelial-mesenchymal transitions in cancer.

Authors: Dingcheng Gao; Linda T Vahdat; Stephen Wong; Jenny C Chang; Vivek Mittal
Journal: Cancer Res Date: 2012-09-20 Impact factor: 12.701

13 in total

1. Tumstatin 185-191 increases the sensitivity of non-small cell lung carcinoma cells to cisplatin by blocking proliferation, promoting apoptosis and inhibiting Akt activation.

Authors: Wei Wang; Ping Chen; Min Tang; Junli Li; Yanfang Pei; Shan Cai; Xiao Zhou; Senlin Chen
Journal: Am J Transl Res Date: 2015-08-15 Impact factor: 4.060

2. Inhibition of protein kinase CK2 sensitizes non-small cell lung cancer cells to cisplatin via upregulation of PML.

Authors: Bo Yang; Jinhong Yao; Bai Li; Guoguang Shao; Yongsheng Cui
Journal: Mol Cell Biochem Date: 2017-07-25 Impact factor: 3.396

Review 3. Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts.

Authors: Hideyuki Furumoto; Takuya Kato; Hiroaki Wakiyama; Aki Furusawa; Peter L Choyke; Hisataka Kobayashi
Journal: Biomedicines Date: 2022-04-04

4. Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.

Authors: Tao Zhang; Ting-Ting Yu; Dong-Ming Zhang; Xiao-Ming Hou; Xiao-Jun Liu; Da Zhao; Li Shan
Journal: Med Oncol Date: 2014-04-20 Impact factor: 3.064

5. An official American Thoracic Society/European Respiratory Society statement: the role of the pulmonologist in the diagnosis and management of lung cancer.

Authors: Mina Gaga; Charles A Powell; Dean E Schraufnagel; Nicolas Schönfeld; Klaus Rabe; Nicholas S Hill; Jean-Paul Sculier
Journal: Am J Respir Crit Care Med Date: 2013-08-15 Impact factor: 21.405

6. Clinical value of microRNA-23a upregulation in non-small cell lung cancer.

Authors: Wei-Qing Qu; Lei Liu; Zhe Yu
Journal: Int J Clin Exp Med Date: 2015-08-15

7. The efficacy and safety of PD-1/PD-L1 inhibitors versus chemotherapy in patients with previously treated advanced non-small-cell lung cancer: A meta-analysis.

Authors: Lin-Guang-Jin Wu; Dan-Ni Zhou; Ting Wang; Jun-Zhi Ma; Hua Sui; Wan-Li Deng
Journal: Medicine (Baltimore) Date: 2021-03-26 Impact factor: 1.817